Doussot B, Doussot A, Ayav A, Santucci N, Deguelte S, Sow AK, El Amrani M, Duvillard L, Piessen G, Girard E, Mabrut JY, Garnier J, Ortega-Deballon P, Fournel I, Facy O

Ann Surg Open. 2024 09;5(3):e492

Hypertriglyceridemia Results From an Impaired Catabolism of Triglyceride-Rich Lipoproteins in -Related Lipodystrophy.

Vergès B, Vantyghem MC, Reznik Y, Duvillard L, Rouland A, Capel E, Vigouroux C

Arterioscler Thromb Vasc Biol. 2024 06 20;:

Plasma 16:0 ceramide as a marker of cardiovascular risk estimated by carotid intima-media thickness in people with type 2 diabetes.

Denimal D, Duvillard L, Béland-Bonenfant S, Terriat B, Pais-de-Barros JP, Simoneau I, Rouland A, Houbachi L, Bouillet B, Vergès B, Petit JM

Diabetes Metab. 2024 05 4;:101542

No effect of liraglutide on high density lipoprotein apolipoprotein AI kinetics in patients with type 2 diabetes.

Duvillard L, de Barros JP, Rouland A, Simoneau I, Denimal D, Bouillet B, Petit JM, Vergès B

Diabetes Metab. 2024 04 21;:101535

Plasma ceramides are associated with MRI-based liver fat content but not with noninvasive scores of liver fibrosis in patients with type 2 diabetes.

Denimal D, Béland-Bonenfant S, Pais-de-Barros JP, Rouland A, Bouillet B, Duvillard L, Vergès B, Petit JM

Cardiovasc Diabetol. 2023 11 8;22(1):310

Liraglutide reduces plasma dihydroceramide levels in patients with type 2 diabetes.

Denimal D, Bergas V, Pais-de-Barros JP, Simoneau I, Demizieux L, Passilly-Degrace P, Bouillet B, Petit JM, Rouland A, Bataille A, Duvillard L, Vergès B

Cardiovasc Diabetol. 2023 05 4;22(1):104

High-Density Lipoprotein Alterations in Type 2 Diabetes and Obesity.

Denimal D, Monier S, Bouillet B, Vergès B, Duvillard L

Metabolites. 2023 02 9;13(2):

HDL functionality in type 1 diabetes: enhancement of cholesterol efflux capacity in relationship with decreased HDL carbamylation after improvement of glycemic control.

Denimal D, Monier S, Simoneau I, Duvillard L, Vergès B, Bouillet B

Cardiovasc Diabetol. 2022 08 12;21(1):154

Identification of a Gain-of-Function Variant as a Novel Cause of Familial Combined Hypocholesterolemia.

Dijk W, Di Filippo M, Kooijman S, van Eenige R, Rimbert A, Caillaud A, Thedrez A, Arnaud L, Pronk A, Garçon D, Sotin T, Lindenbaum P, Garcia EO, Pais de Barros JP, Duvillard L, Si-Tayeb K, Amigo N, Le Questel JY, Rensen PCN, Le May C, Moulin P, Cariou B

Circulation. 2022 07 28;:101161CIRCULATIONAHA121057978

Liraglutide reduces plasma PCSK9 in patients with type 2 diabetes not treated with statins.

Vergès B, Hassid J, Rouland A, Bouillet B, Simoneau I, Petit JM, Duvillard L

Diabetes Metab. 2021 Sep 19;:101284

Liraglutide Increases the Catabolism of Apolipoprotein B100-Containing Lipoproteins in Patients With Type 2 Diabetes and Reduces Proprotein Convertase Subtilisin/Kexin Type 9 Expression.

Vergès B, Duvillard L, Pais de Barros JP, Bouillet B, Baillot-Rudoni S, Rouland A, Petit JM, Degrace P, Demizieux L

Diabetes Care. 2021 Feb 2;:

Increased body fat mass reduces the association between fructosamine and HbA1c in obese type 2 diabetic patients.

Vergès B, Rouland A, Baillot-Rudoni S, Brindisi MC, Duvillard L, Simoneau I, Legris P, Petit JM, Bouillet B

J Diabetes Investig. 2020 Aug 7;:

Plasma apolipoprotein C1 concentration is associated with plasma triglyceride concentration but not with visceral fat and liver fat content in people with type 1 diabetes.

Bouillet B, Gautier T, Rouland A, Duvillard L, Petit JM, Lagrost L, Vergès B

Acta Diabetol. 2019 May 22;:

Plasma Renin Concentration is Associated with Hemodynamic Deficiency and Adverse Renal Outcome in Septic Shock.

Nguyen M, Denimal D, Dargent A, Guinot PG, Duvillard L, Quenot JP, Bouhemad B

Shock. 2018 Nov 6;:

Liraglutide Reduces Postprandial Hyperlipidemia by Increasing ApoB48 (Apolipoprotein B48) Catabolism and by Reducing ApoB48 Production in Patients With Type 2 Diabetes Mellitus.

Vergès B, Duvillard L, Pais de Barros JP, Bouillet B, Baillot-Rudoni S, Rouland A, Sberna AL, Petit JM, Degrace P, Demizieux L

Arterioscler. Thromb. Vasc. Biol.. 2018 Jul 19;:

Vitamin D supplementation, bone turnover, and inflammation in HIV-infected patients.

Benguella L, Arbault A, Fillion A, Blot M, Piroth C, Denimal D, Duvillard L, Ornetti P, Chavanet P, Maillefert JF, Piroth L

Med Mal Infect. 2018 Apr 13;:

Liver Fat Content in People with Pituitary Diseases: Influence of Serum IGF1 Levels.

Nguyen A, Ricolfi F, Lemogne B, Aho S, Lemaire S, Bouillet B, Duvillard L, Denimal D, Fourmont C, Loffroy R, Cercueil JP, Verges B, Petit JM

Horm. Metab. Res.. 2018 Apr;50(4):303-307

European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD) and European Association for the Study of Obesity (EASO) clinical practice recommendations for the management of non-alcoholic fatty liver diseas

Sberna AL, Bouillet B, Rouland A, Brindisi MC, Nguyen A, Mouillot T, Duvillard L, Denimal D, Loffroy R, Vergès B, Hillon P, Petit JM

Diabet. Med.. 2018 Mar;35(3):368-375

Evaluation of the new restandardized 25-hydroxyvitamin D assay on the iSYS platform.

Denimal D, Roux S, Duvillard L

Clin. Biochem.. 2018 Feb;52:156-160

Venous thromboembolic events during warm autoimmune hemolytic anemia.

Audia S, Bach B, Samson M, Lakomy D, Bour JB, Burlet B, Guy J, Duvillard L, Branger M, Leguy-Seguin V, Berthier S, Michel M, Bonnotte B

PLoS ONE. 2018 ;13(11):e0207218

Biological diagnosis of primary aldosteronism: summary of new French and international guidelines.

Denimal D, Lemaire S, Duvillard L

Ann. Biol. Clin. (Paris). 2017 Oct;75(5):489-501

Impairment of the Ability of HDL From Patients With Metabolic Syndrome but Without Diabetes Mellitus to Activate eNOS: Correction by S1P Enrichment.

Denimal D, Monier S, Brindisi MC, Petit JM, Bouillet B, Nguyen A, Demizieux L, Simoneau I, Pais de Barros JP, Vergès B, Duvillard L

Arterioscler. Thromb. Vasc. Biol.. 2017 Mar;:

Effect of Liraglutide Therapy on Liver Fat Content in Patients With Inadequately Controlled Type 2 Diabetes: The Lira-NAFLD Study.

Petit JM, Cercueil JP, Loffroy R, Denimal D, Bouillet B, Fourmont C, Chevallier O, Duvillard L, Vergès B

J. Clin. Endocrinol. Metab.. 2017 Feb;102(2):407-415

Effects of Transcranial Magnetic Stimulation on the Hypothalamic-Pituitary Axis in Depression: Results of a Pilot Study.

Meille V, Verges B, Lalanne L, Jonval L, Duvillard L, Chavet-Gelinier JC, Bonin B, Trojak B

J Neuropsychiatry Clin Neurosci. 2017 ;29(1):70-73

Assessment of Folate Status in Obese Patients: Should We Measure Folate in Serum or in Red Blood Cells?

Denimal D, Brindisi MC, Lemaire S, Duvillard L

Obes Surg. 2016 Dec;26(12):3069-3075

2016 Endocrine Society guidelines update for the diagnosis of primary aldosteronism: are the proposed aldosterone-to-renin ratio cut-off values relevant in the era of fully automated immunoassays?

Denimal D, Duvillard L

Ann. Clin. Biochem.. 2016 Nov;53(6):714-715

Plasma apolipoprotein C1 concentration is associated with plasma triglyceride concentration, but not visceral fat, in patients with type 2 diabetes.

Bouillet B, Gautier T, Aho LS, Duvillard L, Petit JM, Lagrost L, Vergès B

Diabetes Metab.. 2016 Sep;42(4):263-6

Evolution of procalcitonin, C-reactive protein and fibrinogen levels in neutropenic leukaemia patients with invasive pulmonary aspergillosis or mucormycosis.

Roques M, Chretien ML, Favennec C, Lafon I, Ferrant E, Legouge C, Plocque A, Golfier C, Duvillard L, Amoureux L, Bastie JN, Maurin-Bernier L, Dalle F, Caillot D

Mycoses. 2016 Jun;59(6):383-90

Le dosage salivaire du cortisol doit être reconnu comme utile en France.

Denimal D, Lemaire S, Duvillard L

Ann. Biol. Clin. (Paris). 2016 Jun;74(3):372-3

Apolipoprotein B is regulated by gonadotropins and constitutes a predictive biomarker of IVF outcomes.

Scalici E, Bechoua S, Astruc K, Duvillard L, Gautier T, Drouineaud V, Jimenez C, Hamamah S

Reprod. Biol. Endocrinol.. 2016 May;14(1):28

ApoA-II HDL Catabolism and Its Relationships With the Kinetics of ApoA-I HDL and of VLDL1, in Abdominal Obesity.

Vergès B, Adiels M, Boren J, Barrett PH, Watts GF, Chan D, Duvillard L, Söderlund S, Matikainen N, Kahri J, Lundbom N, Lundbom J, Hakkarainen A, Aho S, Simoneau-Robin I, Taskinen MR

J. Clin. Endocrinol. Metab.. 2016 Apr;101(4):1398-406

Association between Admission Serum 25-Hydroxyvitamin D Levels and Functional Outcome of Thrombolyzed Stroke Patients.

Daumas A, Daubail B, Legris N, Jacquin-Piques A, Sensenbrenner B, Denimal D, Lemaire-Ewing S, Duvillard L, Giroud M, Béjot Y

J Stroke Cerebrovasc Dis. 2016 Apr;25(4):907-13

Major changes in the sphingophospholipidome of HDL in non-diabetic patients with metabolic syndrome.

Denimal D, Nguyen A, Pais de Barros JP, Bouillet B, Petit JM, Vergès B, Duvillard L

Atherosclerosis. 2016 Mar;246:106-14

Immunity, inflammation and reservoir in patients at an early stage of HIV infection on intermittent ART (ANRS 141 TIPI Trial).

Piroth L, Moinot L, Yeni P, Avettand-Fénoel V, Reynes J, Girard PM, Marchou B, Georget A, Rouzioux C, Autran B, Duvillard L, Chêne G, Fagard C,

J. Antimicrob. Chemother.. 2016 Feb;71(2):490-6

Extreme hyperferritinemia in the setting of acute myeloid leukaemia: a case report of hemophagocytic lymphohistiocytosis.

Denimal D, Ménégaut L, Rossi C, Duvillard L, Masson D

Biochem Med (Zagreb). 2016 ;26(2):255-9

Oxidation-induced loss of the ability of HDL to counteract the inhibitory effect of oxidized LDL on vasorelaxation.

Perségol L, Brindisi MC, Rageot D, Pais de Barros JP, Monier S, Vergès B, Duvillard L

Heart Vessels. 2015 Nov;30(6):845-9

Performance of a new 1,25-dihydroxyvitamin D fully automated assay on IDS-iSYS system.

Denimal D, Lemaire-Ewing S, Duvillard L

Clin. Biochem.. 2015 Nov;48(16-17):1209-10

Interrelationships between the kinetics of VLDL subspecies and HDL catabolism in abdominal obesity: a multicenter tracer kinetic study.

Vergès B, Adiels M, Boren J, Barrett PH, Watts GF, Chan D, Duvillard L, Söderlund S, Matikainen N, Kahri J, Robin I, Taskinen MR

J. Clin. Endocrinol. Metab.. 2014 Nov;99(11):4281-90

A case-control study of pre-operative levels of serum neutrophil gelatinase-associated lipocalin and other potential inflammatory markers in colorectal cancer.

Duvillard L, Ortega-Deballon P, Bourredjem A, Scherrer ML, Mantion G, Delhorme JB, Deguelte-Lardiere S, Petit JM, Bonithon-Kopp C

BMC Cancer. 2014 Dec 3;14:912

Severe hypovitaminosis D correlates with increased inflammatory markers in HIV infected patients.

Ansemant T, Mahy S, Piroth C, Ornetti P, Ewing S, Guilland JC, Croisier D, Duvillard L, Chavanet P, Maillefert JF, Piroth L

BMC Infect. Dis.. 2013 Jan;13:7

Increased erythrocytes n-3 and n-6 polyunsaturated fatty acids is significantly associated with a lower prevalence of steatosis in patients with type 2 diabetes.

Petit JM, Guiu B, Duvillard L, Jooste V, Brindisi MC, Athias A, Bouillet B, Habchi M, Cottet V, Gambert P, Hillon P, Cercueil JP, Verges B

Clin Nutr. 2012 Aug;31(4):520-5

[Microbeads, nanobeads and cytometry: applications to the analysis and purification of cells and biomolecules].

Lizard G, Duvillard L, Wedemeyer N, Muller C, Ghiringhelli F, Cesbron A, Poncelet P, Gallet F, Kahn E, Gambert P, Göhde W

Pathol. Biol.. 2003 Sep;51(7):418-27

Fiche personne Publications

Retrouvez aussi

Personnes

Equipes

Plateformes

Unités de recherche, établissements

Projets de recherche

Publications scientifiques